Empagliflozin's role in early tubular protection for type 2 diabetes patients

Abstract Background Patients with type 2 diabetes often face early tubular injury, necessitating effective treatment strategies. This study aimed to evaluate the impact of the SGLT2 inhibitor empagliflozin on early tubular injury biomarkers in type 2 diabetes patients with normoalbuminuria. Methods...

Full description

Saved in:
Bibliographic Details
Main Authors: Chuangbiao Zhang (Author), Weiwei Ren (Author), Xiaohua Lu (Author), Lie Feng (Author), Jiaying Li (Author), Beibei Zhu (Author)
Format: Book
Published: BMC, 2024-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available